Safety Surveillance through Antiretroviral Pregnancy Registry
Release date: March 17, 2021
Expiration date: March 17, 2022
Estimated time to complete activity: 1.25 hours
This activity is jointly provided by the Annenberg Center for Health Sciences at Eisenhower, the American Academy of HIV Medicine, in collaboration with Postgraduate Institute for Medicine.
This activity is supported by independent educational grants from Gilead Sciences, Janssen Therapeutics, Merck Pharmaceuticals and ViiV Healthcare.
Target Audience
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, pharmacists, and registered nurses; other healthcare providers, such as nutritionists, social workers, and case managers are also encouraged to attend.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the objectives of the Antiretroviral Pregnancy Registry (APR)
- List key findings from analysis of APR data
- Describe four steps to report a drug exposure to the APR
- Identify early warning signals of major tetrogenicity
Faculty
William R. Short, MD, MPH, AAHIVS
Associate Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
Lynne Mofenson, MD
Elizabeth Glaser
Pediatric AIDS Foundation
Angela Scheuerle, MD
University of Texas
Southwestern Medical Center
Jessica Albano, PhD, MPH
Syneos Health
Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and AAHIVM. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Activity #0797-9999-21-043-H05-P. This program is designated for up to 1.25 contact hours (0.125 CEUs) of continuing pharmacy education credit.
Type of Activity: Knowledge
Nursing Continuing Education
Accreditation Statements
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Credit Designation
1.25 contact hours may be earned for successful completion of this activity. Designated for 0.5 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.
Internet
Learners must have internet access to participate in the activity.
Fee Information: There is no fee for this educational activity.
Method of Participation and Request for Credit
There are no fees for participating and receiving CME/CE credit for this activity. During the period March 17, 2021 through March 17, 2022 participants must read the learning objectives and faculty disclosures and study the educational activity.
If you wish to receive acknowledgment for completing this activity, please complete the evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 16211. Upon registering and completing the activity evaluation, your certificate will be made available immediately.
Media: Internet
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Disclosures
The planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.
William Short, MD, MPH, AAHIVS:
Consulting Fees – ViiV
Fees non-CME/CE – ViiV, Janssen
Lynne Mofenson, MD:
Nothing to Disclose
Angela Scheuerle, MD:
Consulting Fees – Syneos Health/Antiretroviral Pregnancy Registry
Jessica Albano, PhD, MPH:
Salary – Syneos Health
Ownership Interest – Syneos Health
Hardware and Software Requirements
CME University requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.